# Consensus vs Lunit

Consensus records 6,014,388 monthly visits with -1.2% month-over-month growth and Freemium pricing. Lunit records 29,181 monthly visits with -12.8% growth and Contact for Pricing pricing.

| Metric | [Consensus](https://openaitools.app/tool/consensus) | [Lunit](https://openaitools.app/tool/lunit) |
| :--- | :--- | :--- |
| Website URL | https://consensus.app | https://www.lunit.io/en |
| Categories | AI Search Engine, AI Research Tool, AI Papers, AI Article Summarizer | AI Healthcare, AI Medical Diagnosis, AI Image Recognition |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 6,014,388 | 29,181 |
| MoM Growth Rate | -1.2% | -12.8% |
| Primary Market | United States | South Korea |
| Direct Visits | 2,918,713 | 8,314 |
| Review Score | 4.7 | 4.6 |
| Saved Count | 31 | 1 |
| Supported Platforms | Website | Website |

## Consensus

Consensus works like a scholarly search engine supercharged by AI. Instead of returning a flat list of PDFs, you ask a natural-language research question and Consensus extracts claims from relevant papers, then shows you what the studies actually find. A Consensus Meter summarizes the weight of evidence for yes/no questions, so you can see at a glance whether scientists largely agree, disagree, or remain divided.

The platform indexes hundreds of millions of peer-reviewed papers spanning medicine, biology, psychology, economics and more. Answers link straight back to the source studies, and you can filter by study design, journal quality, sample size and publication year to separate stronger evidence from weaker signals. Features like Deep Search, Topic Synthesis and Skills let researchers build a working knowledge base over time rather than starting from scratch on every query.

Consensus is designed for researchers, clinicians, students and analysts who need trustworthy signals from the scientific record without drowning in irrelevant results. A free tier gives limited AI-powered searches each month, while paid plans unlock unlimited use, advanced filters and deeper synthesis.

**Pricing & Plans:** Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options.

- **Evidence-grounded answers:** Ask a research question in plain language and get answers synthesized from peer-reviewed studies, with each claim linked to its source paper.
- **Consensus Meter:** A visual summary shows how the scientific literature leans on a yes/no question, indicating agreement, disagreement or mixed evidence.
- **Powerful filters:** Narrow results by study design, sample size, journal quality, publication year and more to prioritize high-quality evidence.
- **Topic synthesis and Deep Search:** Aggregate findings across many studies into structured summaries that map what is known and where the gaps are.
- **Research workspace:** Save papers, organize sources and build a persistent knowledge base for literature reviews and ongoing projects.

**Strengths:** Answers cite real peer-reviewed papers, so claims are verifiable; Consensus Meter makes it easy to gauge scientific agreement at a glance; Rich filters help separate high-quality evidence from weaker studies; Fast, clean interface designed around research workflows

**Limitations:** Free tier caps the number of AI-assisted searches per month; Coverage is strongest for STEM and health fields, lighter for some humanities topics; It guides you toward sources but is not a substitute for reading full papers

[Profile (Markdown)](https://openaitools.app/tool/consensus.md)

## Lunit

Lunit is a medical AI company headquartered in Seoul, South Korea, spun out of deep-learning research and focused squarely on oncology. Rather than chasing general-purpose healthcare AI, it has built two connected product families: one that helps clinicians find cancer earlier in imaging, and one that extracts quantitative biology from tissue to guide treatment and drug development. Its technology is used across a large international footprint spanning more than 10,000 customer sites in over 70 countries, with hundreds of peer-reviewed publications and industry partnerships behind the deployments.

On the screening side, the Lunit INSIGHT family analyzes mammograms and chest radiographs. Lunit INSIGHT MMG handles 2D mammography while Lunit INSIGHT DBT covers 3D breast tomosynthesis, both designed to flag suspicious regions so radiologists can prioritize the studies that need attention most. Lunit INSIGHT CXR does the same for chest X-rays. Around these detection engines Lunit has assembled program-level tooling: density assessment, risk assessment and risk pathways, live mammography reporting, quality management, analytics, and a patient hub, so a screening service can run AI as part of its routine rather than as an isolated experiment.

On the precision oncology side, the Lunit SCOPE portfolio analyzes pathology images. Lunit SCOPE IO quantifies the tumor microenvironment and immune cell infiltration, which matters for immunotherapy strategy, while the Lunit SCOPE IHC Suite supports immunohistochemistry quantification across markers such as HER2 and PD-L1, alongside a genotype prediction tool. These products are aimed at biopharma partners, clinical trial teams, and companion diagnostic development, where reproducible quantitative readouts are the bottleneck. Because Lunit sells to hospitals, screening programs, and pharmaceutical companies, pricing is quoted directly rather than published, and regulatory status differs by market.

**Pricing & Plans:** Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

- **Lunit INSIGHT MMG and DBT:** Deep-learning analysis of 2D and 3D mammography that marks suspicious lesions to help radiologists detect breast cancer earlier and reduce missed findings.
- **Lunit INSIGHT CXR:** Chest X-ray analysis that highlights potential abnormalities such as nodules and other findings, supporting faster triage in high-volume radiology workflows.
- **Lunit SCOPE IO:** Tumor microenvironment analysis that quantifies tumor-infiltrating lymphocytes and immune phenotypes from pathology slides, informing immunotherapy research.
- **Lunit SCOPE IHC Suite:** AI-assisted immunohistochemistry quantification covering HER2, PD-L1, and other markers, including uIHC and a gene-expression prediction tool for standardized scoring.
- **Screening analytics and workflow tools:** Live mammography reporting, risk assessment, risk pathways, quality management, and patient-facing tools that embed AI into the wider screening program.

**Strengths:** Clinically validated radiology AI with documented regulatory clearances and published evidence; Covers two ends of the cancer pathway — screening detection and precision oncology biomarkers — in one vendor relationship; Wide real-world adoption across many countries, which means integrations and workflow lessons already exist; Strong research output and biopharma partnerships support credibility for trial and CDx work

[Profile (Markdown)](https://openaitools.app/tool/lunit.md)

## Frequently Asked Questions

### How do Consensus and Lunit compare in monthly traffic?

Consensus has 6,014,388 monthly visits, while Lunit has 29,181. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Consensus has a month-over-month growth rate of -1.2%; Lunit has -12.8%.

### How does pricing compare?

Consensus: Freemium. Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options. Lunit: Contact for Pricing. Contact for pricing. Lunit sells enterprise software and platform licenses to hospitals, screening programs, and biopharma partners, so commercial terms and deployment costs are quoted directly through its sales team. No public price list is offered.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Perplexity](https://openaitools.app/tool/perplexity-ai) | 88,310,223 | -3.7% | Freemium | Covers general web sources alongside academic papers, but lacks specialized scientific synthesis metrics and consensus ratings. | [.md](https://openaitools.app/tool/perplexity-ai.md) |
| 2 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Completely free access to a massive scholarly index, but offers less automated natural-language evidence synthesis than Consensus. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 3 | [Kagi Search](https://openaitools.app/tool/kagi-search) | 4,647,605 | +3.2% | Free Trial, Paid | A paid, ad-free search engine that answers to its users | [.md](https://openaitools.app/tool/kagi-search.md) |
| 4 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | Provides deeper PDF reading and interactive literature analysis tools, but is less focused on quick evidence aggregation. | [.md](https://openaitools.app/tool/scispace.md) |
| 5 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Performs advanced systematic review data extraction and evidence synthesis, but has a more complex interface than Consensus. | [.md](https://openaitools.app/tool/elicit.md) |
| 6 | [Jenni](https://openaitools.app/tool/jenni) | 1,498,133 | +5.2% | Freemium | The AI workspace where researchers read, write, and cite with every claim traceable to its source | [.md](https://openaitools.app/tool/jenni.md) |
| 7 | [Rayyan](https://openaitools.app/tool/rayyan) | 1,116,437 | +7.9% | Freemium | AI-assisted systematic review software for screening, extraction, and evidence synthesis at scale | [.md](https://openaitools.app/tool/rayyan.md) |
| 8 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Tracks how papers are cited with Smart Citations to gauge reliability, but features a less direct Q&A synthesis. | [.md](https://openaitools.app/tool/scite.md) |
| 9 | [ResearchRabbit](https://openaitools.app/tool/researchrabbit) | 831,571 | +3.1% | Free | Excellent for visual citation mapping and literature discovery, but lacks automated paper Q&A and evidence synthesis. | [.md](https://openaitools.app/tool/researchrabbit.md) |
| 10 | [Connected Papers](https://openaitools.app/tool/connected-papers) | 750,576 | +3.1% | Freemium | Visualizes research connections through interactive graphs for literature discovery, but does not provide direct Q&A synthesis. | [.md](https://openaitools.app/tool/connected-papers.md) |

---
Source: https://openaitools.app/compare/consensus-vs-lunit

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)